Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-11-082965
Filing Date
2011-03-30
Accepted
2011-03-30 16:34:55
Documents
7
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ON FORM 10-K d10k.htm 10-K 1084671
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 3559
3 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9445
4 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9379
5 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 3640
6 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 3704
7 GRAPHIC g140151g81d93.jpg GRAPHIC 45834
  Complete submission text file 0001193125-11-082965.txt   1178816
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 530 SEATTLE WA 98119-4114
Business Address 750 BATTERY STREET SUITE 330 SAN FRANCISCO CA 94111 2062862501
PONIARD PHARMACEUTICALS, INC. (Filer) CIK: 0000755806 (see all company filings)

EIN.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-16614 | Film No.: 11722517
SIC: 2834 Pharmaceutical Preparations